Real-world characteristics, modern antidiabetic treatment patterns, and comorbidities of patients with type 2 diabetes in central and Eastern Europe: retrospective cross-sectional and longitudinal evaluations in the CORDIALLY(®) study

BACKGROUND: Guidelines from 2016 onwards recommend early use of SGLT2i or GLP-1 RA for patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), to reduce CV events and mortality. Many eligible patients are not treated accordingly, although data are lacking for Central and Eastern Europe...

Descripción completa

Detalles Bibliográficos
Autores principales: Prázný, Martin, Suplotova, Lyudmila, Gumprecht, Janusz, Kamenov, Zdravko, Fülöp, Tibor, Medvedchikov, Alexey, Rosenzweig, Doron, Aleksandric, Milos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548172/
https://www.ncbi.nlm.nih.gov/pubmed/36209118
http://dx.doi.org/10.1186/s12933-022-01631-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548172/
https://www.ncbi.nlm.nih.gov/pubmed/36209118
http://dx.doi.org/10.1186/s12933-022-01631-4

Ejemplares similares